newsfilter
← Latest News
ACCESS Newswire·

Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results

European revenues increased 20% compared to same period last yearGross margin of 39% compared to 35% in same period last yearNet loss improved 19% compared to same period last year BOULDER, CO / ACCESSWIRE / August 8,